NCT02958748

Brief Summary

To evaluate change of different immune cellsduring ARDS and its impact on prognosis.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2016

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

November 6, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 8, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
Last Updated

November 8, 2016

Status Verified

November 1, 2016

Enrollment Period

2 years

First QC Date

November 6, 2016

Last Update Submit

November 6, 2016

Conditions

Intensive Care MedicineARDS

Outcome Measures

Primary Outcomes (1)

  • mortality

    28-day

Study Arms (2)

ARDS

Patients admitted to ICU with diagnosis of ARDS,which happened in 48hours.

Other: taking blood sample

Control

Heathy vonlunteers

Other: taking blood sample

Interventions

taking blood sampleOTHER
ARDSControl

Eligibility Criteria

Age16 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Diagnosis:ARDS(The Berlin definition），onset within 48hours Without past history which may impact immune function

You may qualify if:

  • ①sign on the acknowledged
  • ②Diagnosis with ARDS(The Berlin definition），onset within 48hours

You may not qualify if:

  • ①diagnosis of hematological or immunological disease
  • ②treatment with chemotherapy agents or corticosteroids within 6 months prior to or during the hospitalization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Blood Specimen Collection

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

November 6, 2016

First Posted

November 8, 2016

Study Start

November 1, 2016

Primary Completion

November 1, 2018

Last Updated

November 8, 2016

Record last verified: 2016-11